David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Flowers Foods
FLO
$1.54B
| $13.9M | 0.02% |
753,122
+501,569
| +199% | +$9.51M |
|
677
Blackstone Mortgage Trust
BXMT
$2.38B
| $13.9M | 0.02% |
515,966
-159,886
| -24% | -$4.03M |
|
678
Century Aluminum
CENX
$4.32B
| $13.9M | 0.02% |
1,965,130
+1,937,636
| +7,047% | +$10.7M |
|
679
Evertec
EVTC
$1.77B
| $13.8M | 0.02% |
989,037
+177,037
| +22% | +$2.39M |
|
680
Orthofix Medical
OFIX
$399M
| $13.8M | 0.02% |
332,538
+7,831
| +2% | +$307K |
|
681
CALL
Oracle
ORCL
$410B
| $13.8M | 0.02% |
336,600
+54,800
| +19% | +$2.03M |
|
|
WBA
682
PUT
DELISTED
Walgreens Boots Alliance
WBA
| $13.7M | 0.02% |
163,100
-1,967,300
| -92% | -$157M |
|
|
CVG
683
DELISTED
Convergys
CVG
| $13.7M | 0.02% |
493,781
-41,972
| -8% | -$1.05M |
|
684
Ryman Hospitality Properties
RHP
$9.05B
| $13.7M | 0.02% |
265,987
-93,782
| -26% | -$4.53M |
|
685
iShares Biotechnology ETF
IBB
$10.7B
| $13.5M | 0.02% |
155,700
-15,933
| -9% | -$1.42M |
|
686
Sony
SONY
$142B
| $13.5M | 0.02% |
2,631,340
+2,472,890
| +1,561% | +$11.3M |
|
|
APOL
687
DELISTED
Apollo Education Group Inc Class A
APOL
| $13.5M | 0.02% |
1,642,200
+266,111
| +19% | +$2.12M |
|
688
FirstEnergy
FE
$26.9B
| $13.5M | 0.02% |
374,145
+307,629
| +462% | +$10.3M |
|
689
Fabrinet
FN
$15.1B
| $13.5M | 0.02% |
415,797
+22,365
| +6% | +$602K |
|
690
Terex
TEX
$7.53B
| $13.4M | 0.02% |
540,565
-149,309
| -22% | -$3.13M |
|
691
CALL
Mastercard
MA
$525B
| $13.4M | 0.02% |
142,300
-162,100
| -53% | -$14.3M |
|
|
CY
692
DELISTED
Cypress Semiconductor
CY
| $13.4M | 0.02% |
1,552,694
+1,196,160
| +335% | +$9.66M |
|
|
TLRD
693
DELISTED
Tailored Brands, Inc.
TLRD
| $13.4M | 0.02% |
+749,038
| New | +$11.5M |
|
694
Ambev
ABEV
$45B
| $13.4M | 0.02% |
2,587,974
-2,600,841
| -50% | -$12M |
|
695
ArcelorMittal
MT
$54.8B
| $13.4M | 0.02% |
973,941
-1,344,204
| -58% | -$13M |
|
696
Hartford Financial Services
HIG
$37.6B
| $13.4M | 0.02% |
290,378
-57,251
| -16% | -$2.41M |
|
697
Advanced Micro Devices
AMD
$746B
| $13.4M | 0.02% |
4,686,565
-366,933
| -7% | -$834K |
|
698
MKS Inc
MKSI
$18.2B
| $13.3M | 0.02% |
354,492
+74,329
| +27% | +$2.54M |
|
699
Melco Resorts & Entertainment
MLCO
$2.08B
| $13.3M | 0.02% |
806,353
+361,330
| +81% | +$5.48M |
|
700
Coherent
COHR
$53.9B
| $13.3M | 0.02% |
611,774
+172,104
| +39% | +$3.42M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.